Evidence map›Paper›PMID 41422941›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2026

EU-Africa partnerships in health research from 2014 to 2023: Outputs and lessons learnt.

Debora Bade, Andreia Coelho, Dominika Jajkowicz, Henrique Pinheiro, Thomas Nyirenda, Michael Makanga, Pauline Beattie

Abstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Debora BadeEuropean & Developing Countries Clinical Trials Partnership (EDCTP), The Hague, The Netherlands. Electronic address: bade@edctp.org.
Andreia CoelhoEuropean & Developing Countries Clinical Trials Partnership (EDCTP), The Hague, The Netherlands.
Dominika JajkowiczEuropean & Developing Countries Clinical Trials Partnership (EDCTP), The Hague, The Netherlands; United Nations University World Institute for Development Economics Research, Helsinki, Finland.
Henrique PinheiroAnalytical Services, Elsevier, Montreal, Canada.
Thomas NyirendaEDCTP Association, Cape Town, South Africa.
Michael MakangaGlobal Health EDCTP3 Joint Undertaking, Brussels, Belgium.
Pauline BeattieEuropean & Developing Countries Clinical Trials Partnership (EDCTP), The Hague, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe European & Developing Countries Clinical Trials Partnership (EDCTP) supports clinical research partnerships between countries in Europe and sub-Saharan Africa. A bibliometric analysis of outputs from the second EDCTP program, EDCTP2, was undertaken to assess its contribution to international collaboration, advancement of scientific knowledge and policy uptake.

methods1429 papers acknowledging EDCTP2 support published between 2014 and the end of 2023 were compared with all publications within the scope of EDCTP2 and with subsets acknowledging other funders.

results86.3% of EDCTP2 publications included at least one author from sub-Saharan Africa (SSA) and 62% included authors from both European and SSA countries. SSA researchers were first or last authors on 71% of EDCTP2 papers and women researchers from SSA were lead authors on 33% of EDCTP2 papers. Collaborations across several European-African and African-African country pairs were over-represented in EDCTP2 outputs. EDCTP2 papers were more likely than those from other funders to focus on the affordability and accessibility of medical interventions and on populations with unmet medical needs typically excluded from clinical studies, such as children, pregnant women and people with co-infections and co-morbidities. We corroborated that EDCTP publications were influencing policy.

conclusionAlthough the findings reflect outputs part-way through the EDCTP2 program, they provide encouraging signs that the EDCTP2 program is meeting its objectives on promoting international collaboration, widening access to interventions, and delivering public health benefits to populations in sub-Saharan Africa.

fundingThis work was supported by the UK National Institute for Health and Care Research (NIHR) and the EDCTP2 program, supported by the European Union.

Indexed as

Biomedical ResearchInternational CooperationAfrica South of the SaharaBibliometricsClinical Trials as TopicDeveloping CountriesEuropeEuropean UnionFemaleHumansClinical research capacityClinical trialsDevelopment of medical interventions for the main infectious diseases affecting sub Saharan AfricaNorth-South and South- South partnershipsResearch equityResearch financing

Identifiers

PMID41422941
PMCPMC12979001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.